Harbour Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179K | Sell |
403
-7
| -2% | -$3.12K | ﹤0.01% | 1224 |
|
|
2025
Q1 | $199K | Buy |
410
+68
| +20% | +$33K | 0.01% | 1100 |
|
|
2024
Q4 | $138K | Buy |
342
+1
| +0.3% | +$403 | ﹤0.01% | 1205 |
|
|
2024
Q3 | $159K | Sell |
341
-44
| -11% | -$20.5K | ﹤0.01% | 1115 |
|
|
2024
Q2 | $180K | Buy |
385
+15
| +4% | +$7.03K | 0.01% | 988 |
|
|
2024
Q1 | $155K | Buy |
370
+57
| +18% | +$23.8K | 0.01% | 1023 |
|
|
2023
Q4 | $127K | Buy |
313
+51
| +19% | +$20.8K | 0.01% | 1040 |
|
|
2023
Q3 | $91.1K | Sell |
262
-13
| -5% | -$4.52K | ﹤0.01% | 1087 |
|
|
2023
Q2 | $96.8K | Buy |
275
+6
| +2% | +$2.11K | ﹤0.01% | 1074 |
|
|
2023
Q1 | $84.8K | Sell |
269
-65
| -19% | -$20.5K | ﹤0.01% | 1116 |
|
|
2022
Q4 | $96.5K | Buy |
334
+45
| +16% | +$13K | 0.01% | 1019 |
|
|
2022
Q3 | $81K | Hold |
289
| – | – | 0.01% | 1066 |
|
|
2022
Q2 | $81K | Buy |
+289
| New | +$81K | 0.01% | 1066 |
|
|
2021
Q4 | $98K | Sell |
444
-838
| -65% | -$185K | 0.01% | 976 |
|
|
2021
Q3 | $233K | Buy |
1,282
+148
| +13% | +$26.9K | 0.01% | 947 |
|
|
2021
Q2 | $229K | Buy |
1,134
+102
| +10% | +$20.6K | 0.01% | 981 |
|
|
2021
Q1 | $222K | Buy |
+1,032
| New | +$222K | 0.01% | 918 |
|